CNN/Money 
News > Companies
graphic

Stewart jury eyes perjury charge
Deliberations Thursday end without a verdict, but the panel seeks more information on her ex-broker.
March 4, 2004: 5:38 PM EST

NEW YORK (CNN/Money) - Jurors ended a second day of deliberations in the Martha Stewart trial without reaching a verdict Thursday but appeared to be focusing a charge of perjury against Stewart's former broker, Peter Bacanovic.

The jurors sent a note to the judge Thursday afternoon, asking about what was needed to convict Bacanovic on a charge of perjury. They wanted to know if the testimony of a witness and a document produced by the same witness were separate pieces of evidence.

"I think the short answer is, yes," Judge Miriam Goldman Cedarbaum responded.

The start of deliberations was postponed Thursday morning because four jurors were delayed by a subway accident.

After starting an hour late, the jury asked for testimony from an SEC investigator concerning interviews with Bacanovic.

Then after lunch they sent another note to the judge, asking for e-mails between Bacanovic and Stewart and Stewart's business manager and later, for the standards of evidence needed to convict on Count 6, the perjury charge against Bacanovic.

The panel of eight women and four men began weighing the evidence Wednesday afternoon as they sought to determine if Stewart and her ex-broker lied about her sale of ImClone Systems Inc. stock in late 2001.

The jurors then asked for testimony from the government's star witness, Bacanovic's ex-assistant, Douglas Faneuil, about phone calls with his boss and Stewart on Dec. 27, 2001, the date of the ImClone sale.

Close to the end of the day, the jury asked to see the worksheet on which Bacanovic noted "60" next to ImClone's stock symbol, as well as phone records from Stewart's assistant and transcripts of some of the interviews Bacanovic had with the SEC.

Stewart's lead attorney Robert Morvillo declined to speculate on an expected timeframe for the jury's decision, calling the process "a crap shoot at this point."

"You can't read anything into the early notes," he told CNNfn.

The jurors received the obstruction of justice case after Judge Cedarbaum instructed them for one hour and 40 minutes Wednesday morning.

Related Links
graphic
Opinion (U.S. v. Stewart and Bacanovic)
Superseding Indictment (U.S. v. Stewart and Bacanovic)
Court Ruling Dismissing 'Selective Prosecution' Defense
Stewart's Employment Agreement at Martha Stewart Living Omnimedia Inc.

Her comments were basic, telling the 12 jurors that they alone will decide the defendants' fate and praising them for performing their civic duty. She pointed out that guilt and innocence are personal and not collective. "You may find one defendant guilty without finding the other defendant guilty," she said.

"There is no magic formula by which you should evaluate testimony," the judge told the jurors after detailing instructions for each of the eight remaining counts in the case. "In your everyday affairs, you determine the reliability of statements. The same test should apply."

Stewart and Bacanovic are charged with lying to investigators about the circumstances surrounding Stewart's stock sale on Dec. 27, 2001, the day before regulators rejected the company's application for ImClone's experimental cancer drug -- news that sent its stock tumbling. Both have denied wrongdoing.

Last week, Judge Cedarbaum dismissed a securities fraud charge against the 62-year-old Stewart. The four remaining charges she faces, and the five faced by Bacanovic, each carry a sentence of up to five years.

YOUR E-MAIL ALERTS
Martha Stewart
ImClone Systems Incorporated
Peter Bacanovic

The prosecution alleges Stewart sold her ImClone stock only after Bacanovic told Faneuil to tip her off that ImClone founder Sam Waksal was trying to sell.

Stewart and Bacanovic have told investigators they had an arrangement to sell once the stock fell to $60.

Bacanovic was broker to both Stewart and Waksal, who is serving a seven-year prison term after pleading guilty to securities fraud over his family's sale of ImClone shares.  Top of page


-- from CNNfn's Allan Chernoff and staff and wire reports




  More on NEWS
JPMorgan dramatically slashes Tesla's stock price forecast
Greece is finally done with its epic bailout binge
Europe is preparing another crackdown on Big Tech
  TODAY'S TOP STORIES
7 things to know before the bell
SoftBank and Toyota want driverless cars to change the world
Aston Martin falls 5% in its London IPO




graphic graphic

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.